Appiano Gentile, Italy

Juergen Moll

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Juergen Moll: A Pioneer in Anticancer Therapies

Introduction

Juergen Moll, located in Appiano Gentile, Italy, is an accomplished inventor with a focus on innovative therapeutic combinations for cancer treatment. With a total of two patents to his name, he has made significant contributions to the field of oncology through his inventions.

Latest Patents

Moll's latest patents reflect his commitment to advancing cancer therapy. One notable patent is for a therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent. This invention presents a unique combination of a compound of formula (I) with various antineoplastic agents such as antimetabolites, alkylating agents, and topoisomerase inhibitors, aimed at treating tumors effectively.

Another significant patent focuses on the use of a kinase inhibitor for resistant tumors. The low molecular weight compounds, specifically tetrahydropyrrolo[3,4-c]pyrazoles, have shown a strong affinity for the ATP pocket of ABL tyrosine kinase. These compounds serve as ATP-competitive inhibitors, proving particularly potent against BCR-ABL inhibitor-resistant T315I ABL mutants, thus offering a promising treatment option for chronic myelogenous leukemia.

Career Highlights

Juergen Moll currently works at Nerviano Medical Sciences S.r.l., where he plays a vital role in developing new cancer therapies. His expertise in chemistry and pharmacology has made him instrumental in the discovery of novel compounds that target resistant cancer strains. His focus on translational research has paved the way for significant advancements in therapeutic protocols.

Collaborations

Throughout his career, Moll has collaborated with prominent researchers, including Barbara Valsasina and Italo Beria. These partnerships have strengthened his research projects and enhanced the innovative capabilities of their combined efforts, particularly in the field of oncology.

Conclusion

Juergen Moll is a prominent inventor whose work is making strides in cancer treatment through innovative therapeutic combinations. His patents not only showcase his ingenuity but also highlight the importance of targeted therapies in overcoming drug resistance in cancer patients. As research continues, Moll's contributions will likely play a vital role in shaping future oncology treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…